- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Ramucirumab – March 2018
Ramucirumab: 100 mg in 10 mL vial, 500 mg in 50 mL vial; Cyramza®
Last updated
29 June 2018